A cancer journal has retracted a 2014 paper after discovering one image had been duplicated in seven other papers. That’s right—the same image appeared in a total of eight papers. For some of the papers, the issues went beyond the single image. According to the retraction notice, several papers contained other duplicated images, as well … Continue reading One image was duplicated in eight papers. Yes, eight.
Two journals have retracted papers by a biologist who was recently found guilty of misconduct by his former employer, the University of Colorado Denver, bringing the total to five. The investigation report by UC Denver, which we obtained earlier this year via a public records request, had recommended one of the two newest retractions, which … Continue reading Two more retractions for former US prof who altered dozens of images
A former graduate student at the University of Hong Kong confessed to making “inappropriate modifications” to several figures in a 2013 paper in the Journal of Biological Chemistry (JBC). According to the retraction notice, the authors identified issues in 13 images while reviewing the data; the paper’s first author, Yingying Lu, copped to manipulating the … Continue reading Author admits to manipulating more than a dozen images in 2013 paper
Science Signaling has issued an expression of concern for a 2016 paper, citing an institutional investigation into image manipulation. According to a spokesperson for the journal, the corresponding author, Tanya Kalin, became concerned that two images in the paper had been manipulated. Kalin then notified the research integrity officer at Cincinnati Children’s Hospital Medical Center, … Continue reading Science journal flags cancer paper under investigation for image manipulation
A diabetes researcher who sued a publisher to protect several papers from being retracted recently received his 13th, in a prestigious gastroenterology journal. Mario Saad, based at the University of Campinas in São Paulo, Brazil, has had a string of retractions over the past few years, including four in Diabetes after he lost a legal … Continue reading Diabetes researcher who sued to prevent retractions now has 13
The executive board of the Leibniz Association in Germany has reprimanded the director of its institute on aging for “grossly negligent scientific misconduct.” Besides a written reprimand, the executive board has removed Karl Lenhard Rudolph’s “passive voting rights” in association committees, and excluded the institute under his leadership from receiving funds from a multi-million Euro internal … Continue reading German institute sanctions director after finding him guilty of misconduct
On Dec. 2, 2013, Alison Lakin, the research integrity officer at the University of Colorado Denver, received a concerning email. The emailer was alleging several problems in a 2012 paper in the Journal of Clinical Investigation, co-authored by one of its high-profile faculty members. Lakin discussed the allegations with some administrators and agreed they had … Continue reading Former prof fudged dozens of images, says university
A diabetes researcher who once sued a publisher to prevent several retractions has just issued his 12th. The latest retraction, like several others for Mario Saad, appears in the journal Diabetes. Although in the past Saad expended considerable effort to protect four other Diabetes papers from this same fate, the latest retraction was initiated by the authors, citing several duplicated images. … Continue reading Researcher who sued to prevent retractions now has 12
When journals learn papers are problematic, how long does it take them to act? We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of … Continue reading A university asked for numerous retractions. Eight months later, three journals have done nothing.
A prominent diabetes researcher based at Harvard Medical School has retracted a third paper, citing manipulation of multiple figures. Late last year, Carl Ronald Kahn—also chief academic officer at Joslin Diabetes Center—retracted two papers for similar reasons. In November, Kahn pulled a 2005 paper from The Journal of Clinical Investigation (JCI) and a month later, he retracted a 2003 paper from The … Continue reading Harvard diabetes researcher retracts third paper